Man Group
BEAT

Man Group’s BioTelemetry, Inc. BEAT Stock Holding History

Man Group’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16,438
Closed -$1.19M – 2097
2020
Q4 		$1.19M Sell
16,438
-101,573
-86% -$5.32M 0.01% 1368
2020
Q3 		$5.38M Buy
118,011
+44,361
+60% +$1.85M 0.02% 774
2020
Q2 		$3.33M Sell
73,650
-126,663
-63% -$5.68M 0.02% 851
2020
Q1 		$7.71M Buy
200,313
+91,916
+85% +$4.23M 0.05% 366
2019
Q4 		$5.02M Buy
108,397
+21,219
+24% +$919K 0.02% 995
2019
Q3 		$3.55M Buy
87,178
+15,153
+21% +$654K 0.01% 1031
2019
Q2 		$3.47M Buy
72,025
+49,827
+224% +$2.62M 0.01% 1101
2019
Q1 		$1.39M Buy
+22,198
New +$1.52M 0.01% 1476

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Man Group's BEAT Position: Q1 2021 in Review

Man Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 16,438 shares — an estimated $1.19M sold.

Man Group first reported a position in BEAT in Q1 2019 and held it in 8 quarters. The position peaked at $7.71M in Q1 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Man Group reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Man Group sold 16,438 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.19M.
  • Man Group first reported a position in BioTelemetry, Inc. in Q1 2019 and held it in 8 quarters.
  • Man Group's BioTelemetry, Inc. position peaked at $7.71M in Q1 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Man Group's 13F filing for Q1 2021, filed 17 May 2021.